Literature DB >> 22952295

Trends in 'cure' fraction from colorectal cancer by age and tumour stage between 1975 and 2000, using population-based data, Osaka, Japan.

Yuri Ito1, Tomio Nakayama, Isao Miyashiro, Tomoyuki Sugimoto, Akiko Ioka, Hideaki Tsukuma, Manar E Abdel-Rahman, Bernard Rachet.   

Abstract

Since the 1960s, Japan has experienced a striking increase in the incidence of colorectal cancer, now the second most common cancer in the country. Meanwhile, the management of colorectal cancer has changed dramatically with the implementation of, for example, screening, endoscopy and adjuvant chemotherapy. It is therefore of interest to monitor the long-term trends in population 'cure' in Japan. We analysed 33 885 colorectal cancer cases diagnosed between 1975 and 2000 in Osaka. We applied the multivariable mixture cure model to estimate cure fraction and median survival time (MST) for 'uncured' patients, by sex, age, stage, period at diagnosis and subsite. For colon cancer, the cure fraction increased by about 25%, while MST for the uncured was prolonged from 8 to 12 months. The cure fraction was 5% higher in men than in women, while MST was similar in both. The cure fraction also increased for localized and regional tumours. For rectal cancer, the cure fraction increased by about 25-30%, but remained lower than for colon cancer. From the late 1970s, the cure fraction for colorectal cancer increased dramatically due to better management of detection and care for colorectal cancer. This improvement was obtained at the cost of shorter MST for uncured patients.

Entities:  

Mesh:

Year:  2012        PMID: 22952295     DOI: 10.1093/jjco/hys132

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  5 in total

1.  Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.

Authors:  Margaret R Stedman; Eric J Feuer; Angela B Mariotto
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

2.  Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients.

Authors:  Swee Sung Soon; Whay-Kuang Chia; Mun-ling Sarah Chan; Gwo Fuang Ho; Xiao Jian; Yan Hong Deng; Chuen-Seng Tan; Atul Sharma; Eva Segelov; Shaesta Mehta; Raghib Ali; Han-Chong Toh; Hwee-Lin Wee
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

Review 3.  Cancer control programs in East Asia: evidence from the international literature.

Authors:  Malcolm A Moore
Journal:  J Prev Med Public Health       Date:  2014-07-31

4.  Proximal shift of colorectal cancer with increasing age in different ethnicities.

Authors:  Lin Yang; Zhenchong Xiong; Wenzhuo He; Kunqian Xie; Shousheng Liu; Pengfei Kong; Chang Jiang; Guifang Guo; Liangping Xia
Journal:  Cancer Manag Res       Date:  2018-08-15       Impact factor: 3.989

5.  Characterisation of long-term cancer survivors and application of statistical cure models: a protocol for an observational follow-up study in patients with colorectal cancer.

Authors:  Sonia Pértega-Díaz; Vanesa Balboa-Barreiro; Rocío Seijo-Bestilleiro; Cristina González-Martín; Remedios Pardeiro-Pértega; Loreto Yáñez-González-Dopeso; Teresa García-Rodríguez; Teresa Seoane-Pillado
Journal:  BMC Public Health       Date:  2020-11-17       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.